Study of active components and mechanisms mediating the hypolipidemic effect of Inonotus obliquus polysaccharides

Abstract

Hyperlipidemia is a multifaceted metabolic disease, which is the major risk factor for atherosclerosis and cardiovascular diseases. Traditional Chinese medicine provides valuable therapeutic strategies in the treatment of hyperlipidemia. Inonotus obliquus has been used in traditional medicine to treat numerous diseases for a long time. To screen and isolate the fractions of I. obliquus polysaccharides (IOP) that can reduce blood lipid in the hyperlipemia animals and cell models, and investigate its mechanisms. The active component IOP‐A2 was isolated, purified, and identified. In vivo, rats were randomly divided into blank control group (NG), the high‐fat treatment group (MG), lovastatin group (PG), and IOP‐A group. Compared with MG, the hyperlipidemic rats treated with IOP‐A2 had decreased body weight and organ indexes, with the level of serum total cholesterol (TC), triglyceride (TG), and low‐density lipoprotein cholesterol (LDL‐C) significantly decreased (p < .05), and level of serum high‐density lipoprotein cholesterol (HDL‐C) significantly increased (p < .05). Hepatocyte steatosis in hepatic lobules was significantly reduced. In vitro, the accumulation of lipid droplets in the model of fatty degeneration of HepG2 cells was significantly alleviated, and cellular TC and TG content was significantly decreased (p < .01). Moreover, the expression of recombinant cytochrome P450 7A1 (CYP7A1) and Liver X Receptor α (LXRα) were up‐regulated (p < .05) both in vivo and in vitro. The results showed that IOP‐A2 may exert its hypolipidemic activity by promoting cholesterol metabolism and regulating the expression of the cholesterol metabolism‐related proteins CYP7A1, LXRα, SR‐B1, and ABCA1.